Expansion of SCG/GCG-Based CAD Sceering: Inclusion of Healthy Controls and CCTA Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1600 participants.
Also called NCT06880133
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 1,600 participants
- Sponsor
- Heart Force Medical Inc.
- Registry
-
NCT06880133
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Uzbekistan
- Registry status
- Completed
Technical summary
Registry record NCT06880133. Allocation not applicable; no masking; primary purpose screening. Start 2021-11-12 (actual); primary completion 2023-12-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Expansion of SCG/GCG-Based CAD Sceering: Inclusion of Healthy Controls and CCTA Patients
- Acronym
- HF-CAD-CCTA
- Condition
- Coronary Artery Disease (CAD (coronary artery disease)) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
- Intervention (Device)
- Seismocardiography (SCG) and Gyrocardiography (GCG) Screening
- Lead sponsor
- Heart Force Medical Inc.
Record details
- Record id
cardio:ct-nct06880133- Content hash
fc2053a166b92e4ca4d0754351a31230fcbd908114230c5dc3a6edd530ac6452